tiprankstipranks
Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
US Market
TARS
Tarsus Pharmaceuticals
RESEARCH TOOLSreports

Tarsus Pharmaceuticals (TARS) Stock News & Sentiment

266 Followers
Buy Rating Backed by Blockbuster Xdemvy Launch and TP-05 Lyme Prevention Opportunity
Premium
Ratings
Buy Rating Backed by Blockbuster Xdemvy Launch and TP-05 Lyme Prevention Opportunity
10d ago
TARS
Tarsus Pharmaceuticals Bets Big on XDEMVY Growth
Premium
Company Announcements
Tarsus Pharmaceuticals Bets Big on XDEMVY Growth
1M ago
TARS
Sustained Growth Outlook for Tarsus Driven by XDEMVY’s Rapid Ramp and Expanding Lotilaner Pipeline
Premium
Ratings
Sustained Growth Outlook for Tarsus Driven by XDEMVY’s Rapid Ramp and Expanding Lotilaner Pipeline
2M ago
TARS
Tarsus: Strong Xdemvy Launch, Upgraded Long‑Term Outlook, and Underappreciated Earnings Power Support Buy Rating
Premium
Ratings
Tarsus: Strong Xdemvy Launch, Upgraded Long‑Term Outlook, and Underappreciated Earnings Power Support Buy Rating
2M ago
TARS
Tarsus: Raising Peak Xdemvy Outlook to $2B+ on Strong Q4 Momentum and Pipeline Upside
Premium
Ratings
Tarsus: Raising Peak Xdemvy Outlook to $2B+ on Strong Q4 Momentum and Pipeline Upside
2M ago
TARS
TARS Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
TARS Upcoming Earnings Report: What to Expect?
2M ago
TARS
Tarsus Pharmaceuticals Adds Industry Veteran to Board
Premium
Company Announcements
Tarsus Pharmaceuticals Adds Industry Veteran to Board
2M ago
8K
TARS
More TARS News >

TARS News on the Web

Analysts Offer Insights on Healthcare Companies: Alterity Therapeutics (OtherPRNAF), Tarsus Pharmaceuticals (TARS) and enGene Holdings (ENGN)
TipRanks News
Bullish
Tarsus Pharmaceuticals (TARS) Receives a Buy from LifeSci Capital
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS) and Forte Biosciences (FBRX)
TipRanks News
Neutral
Buy Rating Backed by Blockbuster Xdemvy Launch and TP-05 Lyme Prevention Opportunity
TipRanks News
Bullish
Tarsus Pharmaceuticals doses first participant in TP-05 trial
TipRanks News
Bullish
Barclays Reaffirms Their Buy Rating on Tarsus Pharmaceuticals (TARS)
TipRanks News
Neutral
Analysts’ Top Healthcare Picks: Tarsus Pharmaceuticals (TARS), IDEAYA Biosciences (IDYA)
TipRanks News
Neutral
Tarsus Pharmaceuticals price target raised to $101 from $100 at Mizuho
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TARS’s Media Buzz Sentiment?
Currently, no data Available
What is TARS’s weekly average amount of articles?
Currently, no data Available
What is TARS’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week